Analysed VOYAGEUR PHARMACEUTICALS LTD (VYYRF:OTCMKTS) News Sources
Voyageur Pharmaceuticals Ltd. Strengthens Board of Directors With Seasoned Financial Executive Virginia Alling to Drive U.S. Market Expansion
07-11-2025
yahoo.com
Voyageur Pharmaceuticals Strengthens Scientific Team by Adding Dr. Brian Mueller as Director of Chemistry and Secures Exclusive Ownership of Iodine Extraction Technology
12-01-2026
yahoo.com
Voyageur Pharmaceuticals Ltd. Submits Multi-Year Area-Based Exploration Permit Application for Bulk Sampling and Feasibility Support at Frances Creek Barite Project
10-06-2026
yahoo.com
Voyageur Pharmaceuticals Announces the Engagement of Red Cloud Securities as Market Maker
17-07-2026
yahoo.com
Voyageur Pharmaceuticals Advances Mueller Iodine Extraction Process With 99.8% Purity Results and Planned Field Pilot Testing
10-08-2026
yahoo.com
Voyageur Pharmaceuticals Achieves First Milestone on Feasibility Study for Iodine Production; Secures USD $1 Million Payment
09-09-2026
yahoo.com
What is the current price of VOYAGEUR PHARMACEUTICALS LTD (VYYRF:OTCMKTS)?
The current price of VOYAGEUR PHARMACEUTICALS LTD (VYYRF:OTCMKTS) is $0.095.
VOYAGEUR PHARMACEUTICALS LTD (VYYRF:OTCMKTS) absolute price change since previous trading day?
The absolute price change of VOYAGEUR PHARMACEUTICALS LTD (VYYRF:OTCMKTS) since the previous trading day is $-0.001.
VOYAGEUR PHARMACEUTICALS LTD (VYYRF:OTCMKTS) percentage price change since previous trading day?
The percentage price change of VOYAGEUR PHARMACEUTICALS LTD (VYYRF:OTCMKTS) since the previous trading day is -1.0417%.
What is the most recent average sentiment score for VOYAGEUR PHARMACEUTICALS LTD (VYYRF:OTCMKTS)?
The most recent average sentiment score for VOYAGEUR PHARMACEUTICALS LTD (VYYRF:OTCMKTS) is 71 out of 100.
What is the most recent average sentiment for VOYAGEUR PHARMACEUTICALS LTD (VYYRF:OTCMKTS)?
The most recent sentiment for VOYAGEUR PHARMACEUTICALS LTD (VYYRF:OTCMKTS) is .
SEC-8K** Filing Available For VOYAGEUR PHARMACEUTICALS LTD (VYYRF:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.